BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brinkert F, Pukite I, Krebs-Schmitt D, Briem-Richter A, Stindt J, Häussinger D, Keitel V, Müller I, Grabhorn E. Allogeneic haematopoietic stem cell transplantation eliminates alloreactive inhibitory antibodies after liver transplantation for bile salt export pump deficiency. J Hepatol 2018;69:961-5. [PMID: 29935200 DOI: 10.1016/j.jhep.2018.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gertzen CGW, Gohlke H, Häussinger D, Herebian D, Keitel V, Kubitz R, Mayatepek E, Schmitt L. The many facets of bile acids in the physiology and pathophysiology of the human liver. Biol Chem 2021;402:1047-62. [PMID: 34049433 DOI: 10.1515/hsz-2021-0156] [Reference Citation Analysis]
2 Alam S, Lal BB. Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies. World J Hepatol 2022; 14(1): 98-118 [DOI: 10.4254/wjh.v14.i1.98] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Krebs-Schmitt D, Briem-Richter A, Brinkert F, Keitel V, Pukite I, Lenhartz H, Fischer L, Grabhorn E. Alloimmunity and Cholestasis After Liver Transplantation in Children With Progressive Familial Intrahepatic Cholestasis. J Pediatr Gastroenterol Nutr. 2019;68:169-174. [PMID: 30664572 DOI: 10.1097/mpg.0000000000002200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Henkel SA, Squires JH, Ayers M, Ganoza A, Mckiernan P, Squires JE. Expanding etiology of progressive familial intrahepatic cholestasis. World J Hepatol 2019; 11(5): 450-463 [PMID: 31183005 DOI: 10.4254/wjh.v11.i5.450] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 11.3] [Reference Citation Analysis]
5 Pareja E, Gómez-Lechón MJ, Tolosa L. Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint. Ann Transl Med 2020;8:566. [PMID: 32775367 DOI: 10.21037/atm.2020.02.164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hartley J, Baumann U. Steps Forward in the Management of Familial Cholestasis. J Pediatr Gastroenterol Nutr 2019;68:155-6. [PMID: 30418415 DOI: 10.1097/MPG.0000000000002201] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]